# Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552

> **NCT01110590** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 37 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** BAY60-4552 + Vardenafil
- **DRUG:** BAY60-4552 + Vardenafil
- **DRUG:** BAY60-4552 + Vardenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01110590
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2013-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110590, "Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01110590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*